Correlation Between Cannabis Suisse and Nunzia Pharmaceutical

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Cannabis Suisse and Nunzia Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cannabis Suisse and Nunzia Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cannabis Suisse Corp and Nunzia Pharmaceutical, you can compare the effects of market volatilities on Cannabis Suisse and Nunzia Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cannabis Suisse with a short position of Nunzia Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cannabis Suisse and Nunzia Pharmaceutical.

Diversification Opportunities for Cannabis Suisse and Nunzia Pharmaceutical

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Cannabis and Nunzia is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Cannabis Suisse Corp and Nunzia Pharmaceutical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nunzia Pharmaceutical and Cannabis Suisse is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cannabis Suisse Corp are associated (or correlated) with Nunzia Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nunzia Pharmaceutical has no effect on the direction of Cannabis Suisse i.e., Cannabis Suisse and Nunzia Pharmaceutical go up and down completely randomly.

Pair Corralation between Cannabis Suisse and Nunzia Pharmaceutical

If you would invest  1.30  in Cannabis Suisse Corp on December 29, 2024 and sell it today you would earn a total of  0.50  from holding Cannabis Suisse Corp or generate 38.46% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy96.83%
ValuesDaily Returns

Cannabis Suisse Corp  vs.  Nunzia Pharmaceutical

 Performance 
       Timeline  
Cannabis Suisse Corp 

Risk-Adjusted Performance

Good

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Cannabis Suisse Corp are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. Despite fairly unfluctuating basic indicators, Cannabis Suisse demonstrated solid returns over the last few months and may actually be approaching a breakup point.
Nunzia Pharmaceutical 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Nunzia Pharmaceutical has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Nunzia Pharmaceutical is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

Cannabis Suisse and Nunzia Pharmaceutical Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Cannabis Suisse and Nunzia Pharmaceutical

The main advantage of trading using opposite Cannabis Suisse and Nunzia Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cannabis Suisse position performs unexpectedly, Nunzia Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nunzia Pharmaceutical will offset losses from the drop in Nunzia Pharmaceutical's long position.
The idea behind Cannabis Suisse Corp and Nunzia Pharmaceutical pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.

Other Complementary Tools

Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum